Literature DB >> 8697397

The World Health Organization classification of adenohypophysial neoplasms. A proposed five-tier scheme.

K Kovacs1, B W Scheithauer, E Horvath, R V Lloyd.   

Abstract

BACKGROUND: Although numerous attempts have been made, the classification of pituitary neoplasms remains controversial.
METHODS: The present proposal is based on correlative clinical and pathologic (histologic, immunocytochemical, and electron microscopic) studies of more than 8000 surgically removed human pituitary tumors.
RESULTS: Anterior pituitary tumors have been variously classified on the basis of their clinical presentation, biochemical findings, histology (growth pattern, tinctorial characteristics), proliferation indices, immunocytochemical profile, and ultrastructural features. Herein we propose a five-tier classification, clinicopathologic in nature, which focuses on endocrine activity, imaging, operative findings, histology, immunocytochemistry, and ultrastructure. The integration of these five complementary approaches into what is fundamentally a pathologic classification is as practical as it is novel. Its importance lies in the fact that the collected data provide valuable information to the clinical endocrinologist, neurosurgeon, and oncologist involved in the assessment of a tumor's biologic behavior, growth potential, therapeutic responsiveness, and prognosis. Due to financial restraints, lack of facilities, and unavailability of well trained personnel, we realize that at present the five approaches cannot be fully implemented in all institutions. Nonetheless, clinical and biochemical data, imaging, and operative findings, as well as basic histologic parameters are generally readily available. Collectively they are indispensable in establishing the correct diagnosis and in directing patient management. Conversely, the cost-effectiveness of immunocytochemistry and electron microscopy is debatable in that their performance and interpretation requires time, financial resources, and expertise. Nonetheless, it should be clear that any correlation between endocrine activity, growth potential, morphologic features, immunocytochemical profile, and ultrastructural features provides greater insight into the pathobiology of adenohypophysial tumors than is gained by routine histology alone. Thus we feel justified in including immunocytochemical and ultrastructural investigation of pituitary tumors in a modern classification. At present, more sophisticated molecular biologic methods represent investigative tools that play no significant role in the classification.
CONCLUSIONS: A five-tier classification of adenohypophysial neoplasms based on clinical and biochemical results, imaging, operative findings, histology, immunocytochemistry, and electron microscopy is proposed. It is recommended to the World Health Organization for acceptance.

Entities:  

Mesh:

Year:  1996        PMID: 8697397     DOI: 10.1002/(SICI)1097-0142(19960801)78:3<502::AID-CNCR18>3.0.CO;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo.

Authors:  S Nielsen; S Mellemkjaer; L M Rasmussen; T Ledet; N Olsen; M Bojsen-Møller; J Astrup; J Weeke; J O Jørgensen
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

2.  Vasculogenic Mimicry in Clinically Non-functioning Pituitary Adenomas: a Histologic Study.

Authors:  Joseph Di Michele; Fabio Rotondo; Kalman Kovacs; Luis V Syro; George M Yousef; Michael D Cusimano; Antonio Di Ieva
Journal:  Pathol Oncol Res       Date:  2017-01-13       Impact factor: 3.201

Review 3.  Advances and controversies in the classification and grading of pituitary tumors.

Authors:  E R Laws; D L Penn; C S Repetti
Journal:  J Endocrinol Invest       Date:  2018-06-01       Impact factor: 4.256

Review 4.  Growth factors in the pathogenesis of prolactin-secreting tumors.

Authors:  C Missale; P F Spano
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

5.  Clinical and Epidemiological Characteristics of Pituitary Tumours using a Web-based Pituitary Tumour Registry in Oman.

Authors:  Abdullah Al-Futaisi; Al-Yaarubi Saif; Ibrahim Al-Zakwani; Salim Al-Qassabi; Shaden Al-Riyami; Yasser Wali
Journal:  Sultan Qaboos Univ Med J       Date:  2007-04

Review 6.  Ectopic sphenoid sinus pituitary adenoma (ESSPA) with normal anterior pituitary gland: a clinicopathologic and immunophenotypic study of 32 cases with a comprehensive review of the english literature.

Authors:  Lester D R Thompson; Raja R Seethala; Susan Müller
Journal:  Head Neck Pathol       Date:  2012-03-20

7.  Ghrelin immunoexpression in pituitary adenomas.

Authors:  Fabio Rotondo; Michael Cusimano; Bernd W Scheithauer; Angelo Rotondo; Luis V Syro; Kalman Kovacs
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

Review 8.  Progression of a Nelson's adenoma to pituitary carcinoma; a case report and review of the literature.

Authors:  S A Kemink; P Wesseling; G F Pieters; A A Verhofstad; A R Hermus; A G Smals
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

9.  Prolactin-producing pituitary adenoma associated with prolactin cell hyperplasia.

Authors:  Sergio Vidal; Eva Horvath; Luis V Syro; Humberto Uribe; Sandy Cohen; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

10.  MMP-14 and TGFβ-1 methylation in pituitary adenomas.

Authors:  Kornelija Ruskyte; Rasa Liutkevicienė; Alvita Vilkeviciute; Paulina Vaitkiene; Indre Valiulytė; Brigita Glebauskiene; Loresa Kriauciuniene; Dalia Zaliuniene
Journal:  Oncol Lett       Date:  2016-07-29       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.